Skip to main content
JAMA Network logoLink to JAMA Network
. 2023 Jan 17;80(4):422. doi: 10.1001/jamaneurol.2022.5184

Error in Figure

PMCID: PMC9857839  PMID: 36648932

In the Original Investigation titled “Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease,”1 published in the November 2021 issue, there were errors in the y-axes of the Figure, E and F. The assays were mislabeled and the amyloid-β types were incorrect for panels E and F. This article was corrected online.

Reference

  • 1.Janelidze S, Teunissen CE, Zetterberg H, et al. Head-to-head comparison of 8 plasma amyloid-β 42/40 assays in Alzheimer disease. JAMA Neurol. 2021;78(11):1375-1382. doi: 10.1001/jamaneurol.2021.3180 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Neurology are provided here courtesy of American Medical Association

RESOURCES